JY
PPBT

Jeff Yass’s Purple Biotech PPBT Stock Holding History

Jeff Yass’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-65
Closed -$17.9K – 13273
2022
Q4 		$17.9K Buy
+65
New +$24.9K ﹤0.01% 11797
2022
Q3 		– Sell
-100
Closed -$48K – 13918
2022
Q2 		$48K Sell
100
-29
-22% -$17.4K ﹤0.01% 11996
2022
Q1 		$102K Sell
129
-12
-9% -$7.74K ﹤0.01% 11900
2021
Q4 		$110K Sell
141
-176
-56% -$150K ﹤0.01% 12076
2021
Q3 		$289K Buy
317
+130
+70% +$126K ﹤0.01% 10686
2021
Q2 		$183K Buy
+187
New +$172K ﹤0.01% 11686

Other funds holding PPBT

SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return
IA
IFG Advisory Atlanta, Georgia $2.85B AUM 26.07% 1-Year Est. Return

Jeff Yass's PPBT Position: Q2 2026 in Review

Jeff Yass reduced its Purple Biotech (PPBT) stake by 76% in Q2 2026, selling an estimated $137K and leaving 12,847 shares worth $21.6K. The position accounts for ﹤0.01% of the portfolio, ranked #13031.

Jeff Yass first reported a position in PPBT in Q4 2017 and has held it in 13 quarters since. The position peaked at $309K in Q4 2025. 13 funds tracked by Wall St. Rank hold PPBT as of Q2 2026.

  • Jeff Yass held 12,847 shares of Purple Biotech worth $21.6K as of Q2 2026.
  • Jeff Yass sold 40,556 Purple Biotech shares in Q2 2026, an estimated $137K.
  • Purple Biotech made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13031 holding.
  • Jeff Yass first reported a position in Purple Biotech in Q4 2017 and has held it in 13 quarters since.
  • Jeff Yass's Purple Biotech position peaked at $309K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Purple Biotech as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.